Authors’ relationships and activities
MR
MR received personal fees from Allergan, Eli Lilly, Fishawack Group, Gilead Sciences, Novo Nordisk, Pfizer, Prosciento and Target RWE and investigator-initiated research support from Boehringer-Ingelheim, Nutricia/Danone and Sanofi-Aventis. CH received research support from Sanofi-Aventis and is a member of the Editorial Board of Diabetologia. All other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.